CRKL but not CRKII contributes to hemin‐induced erythroid differentiation of CML
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chunmei Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology & Liaoning Key Laboratory of Cancer Stem Cell Research, College of Basic Medical Sciences, Dalian Medical University, Dal…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Cell Differentiation, Erythroid Cells, Hemin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Destruction of erythropoiesis process leads to various diseases, including thrombocytopenia, anaemia, and leukaemia. miR‐429‐CT10 regulation of kinase‐like (CRKL) axis involved in development, progression and metastasis of cancers. However, the exact role of miR‐429‐CRKL axis in leukaemic cell differentiation are still unknown. The current work aimed to uncover the effect of miR‐429‐CRKL axis on erythropoiesis. In the present study, CRKL upregulation was negatively correlated with miR‐429 downregulation in both chronic myeloid leukaemia (CML) patient and CR patient samples. Moreover, CRKL expression level was significantly decreased while miR‐429 expression level was increased during the erythroid differentiation of K562 cells following hemin treatment. Functional investigations revealed that overexpression and knockdown of CRKL was remarkably effective in suppressing and promoting hemin‐induced erythroid differentiation of K562 cells, whereas, miR‐429 exhibited opposite effects to CRKL. Mechanistically, miR‐429 regulates erythroid differentiation of K562 cells by downregulating CRKL via selectively targeting CRKL ‐3′‐untranslated region (UTR) through Raf/MEK/ERK pathway. Conversely, CRKII had no effect on erythroid differentiation of K562 cells. Taken together, our data demonstrated that CRKL (but not CRKII) and miR‐429 contribute to development, progression and erythropoiesis of CML, miR‐429‐CRKL axis regulates erythropoiesis of K562 cells via Raf/MEK/ERK pathway, providing novel insights into effective diagnosis and therapy for CML patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology & Liaoning Key Laboratory of Cancer Stem Cell Research, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.
- Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.
- Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Institute of Stem Cell Transplantation of Dalian Medical University, Dalian, Liaoning, China.
ORCID-Profile: Chunmei Guo, Ming-Zhong Sun
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, C., Lv, X., Zhang, Q., Yi, L., Ren, Y., Li, Z., Yan, J., Zheng, S., Sun, M. Z., & Liu, S. (2024). CRKL but not CRKII contributes to hemin‐induced erythroid differentiation of CML. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18308
Vancouver
Guo C, Lv X, Zhang Q, Yi L, Ren Y, Li Z, et al. CRKL but not CRKII contributes to hemin‐induced erythroid differentiation of CML. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18308
BibTeX
@article{Guo2024,
author = {Guo, Chunmei and Lv, Xinxin and Zhang, Qiuling and Yi, Lina and Ren, Yingying and Li, Zhaopeng and Yan, Jinsong and Zheng, Shanliang and Sun, Ming-Zhong and Liu, Shuqing},
title = {CRKL but not CRKII contributes to hemin‐induced erythroid differentiation of CML},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18308}
}
EUVIMED